Single-agent high-dose melphalan salvage therapy for Hodgkin's disease: cost, safety, and long-term efficacy (Q74296356)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 December 1997
edit
Language Label Description Also known as
English
Single-agent high-dose melphalan salvage therapy for Hodgkin's disease: cost, safety, and long-term efficacy
scientific article published on 01 December 1997

    Statements

    Single-agent high-dose melphalan salvage therapy for Hodgkin's disease: cost, safety, and long-term efficacy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit